# CENCORA, INC. (COR) FY2026 Q3 Statement of Cash Flows

- Company: CENCORA, INC. (COR)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q3 FY2026 10-Q, filed 2026-08-05, accession number 0001140859-26-000034
- Page: https://plicit.ai/financials/cor/fy2026-q3-cash-flow
- Chart image: https://plicit.ai/charts/cor-fy2026-q3-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 2,236,262,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: 2,654,060,000 US dollars. Net cash provided.
- **Income taxes payable and other liabilities**: 17,363,000 US dollars
- **(Gain) loss on divestiture of businesses**: negative 17,247,000 US dollars
- **Net income**: 776,667,000 US dollars
- **Amortization, including amounts charged to interest expense**: 123,018,000 US dollars
- **Prepaid expenses and other assets**: 107,734,000 US dollars
- **Provision for credit losses**: 11,721,000 US dollars
- **Depreciation, including amounts charged to cost of goods sold**: 154,410,000 US dollars
- **Accounts receivable**: negative 445,946,000 US dollars
- **Provision for deferred income taxes**: 54,884,000 US dollars
- **Other, net**: negative 13,800,000 US dollars
- **Share-based compensation expense**: 28,733,000 US dollars
- **Adjustments to RCA and OneOncology equity units**: 55,167,000 US dollars
- **Türkiye highly inflationary impact**: 15,724,000 US dollars
- **LIFO credit**: negative 94,304,000 US dollars
- **Accounts payable**: 2,827,267,000 US dollars
- **Gain on remeasurement of equity investment**: 6,000,000 US dollars
- **Inventories**: negative 886,857,000 US dollars
- **Accrued expenses**: 36,138,000 US dollars
- **Impairment of assets, including goodwill**: 0 US dollars
- **Gain on sale of assets**: 1,282,000 US dollars
- **Remeasurement gain related to OneOncology acquisition (Note 2)**: 0 US dollars
- **Long-term accrued litigation liability**: negative 103,894,000 US dollars
- **Gain on divestiture of equity investment**: 0 US dollars
- **Investing activities**: negative 240,149,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the investing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from sale of assets), so Proceeds from divestiture of a business and Proceeds from sale of assets cannot be separated for this quarter. It may combine inflows and outflows.
- **Capital expenditures**: negative 226,039,000 US dollars
- **Cost of acquired companies, net of cash acquired**: negative 41,660,000 US dollars
- **Other, net**: 6,963,000 US dollars
- **Non-customer note receivable**: 2,813,000 US dollars
- **Cost of equity investments**: negative 9,269,000 US dollars
- **Remaining investing cash flows, net (calculated)**: 27,043,000 US dollars
- **Financing activities**: negative 1,767,825,000 US dollars. Net cash used.
- **Senior notes and loan repayments**: negative 719,646,000 US dollars
- **Senior notes and loan borrowings**: 39,328,000 US dollars
- **Borrowings under revolving and securitization credit facilities**: 12,884,288,000 US dollars
- **Cash dividends on common stock**: negative 116,589,000 US dollars
- **Repayments under revolving and securitization credit facilities**: negative 12,852,175,000 US dollars
- **Other, net**: negative 2,841,000 US dollars
- **Employee tax withholdings related to restricted share vesting**: negative 138,000 US dollars
- **Purchases of common stock**: negative 1,000,052,000 US dollars
- **Operating adjustment reconciliation**: 3,439,441,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 14,691,441,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing displayed reconciliation**: 276,968,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- **Exchange-rate effect**: 0 US dollars
- **Other changes in cash (calculated)**: negative 17,391,000 US dollars. Out of cash; drawn as the small gray flow above ending cash.
- **Ending cash on Jun 30, 2026**: 2,864,957,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 4,890,322,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 628,695,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: 3.42×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: 2,654,060,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 226,039,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: 2,428,021,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $1.88B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,654,060,000 US dollars minus 226,039,000 US dollars equals 2,428,021,000 US dollars.